[Renin-angiotensin system inhibitors - biochemical and clinical aspects].
D000804:Angiotensin II / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D010436:Pepstatins / Q000494:pharmacology; D010743:Phospholipids / Q000494:pharmacology; D012084:Renin-Angiotensin System / Q000187:drug effects*; D012504:Saralasin / Q000627:therapeutic use; D013722:Teprotide / Q000494:pharmacology; D000092502:Renin Inhibitors
D000804:Angiotensin II; D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril; D010436:Pepstatins; D010743:Phospholipids; D012504:Saralasin; D013722:Teprotide; D000092502:Renin Inhibitors; C014805:angiotensin II, Sar(1)-Thr(8)-
Inhibitory układu reninowo-angiotensynowego - aspekty biochemiczne i kliniczne.